Prophylaxis of postoperative thromboembolism. Randomized prospective study.
Autor(a) principal: | |
---|---|
Data de Publicação: | 1996 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556 |
Resumo: | The difference between a non fractioned heparin (Liquemine) and another of low molecular weight (Fraxiparine) was compared through: hemostasis difficulties, during and after surgery; the use of transfusions; clinical signs of inferior limb vein thrombosis or pulmonary emboli; laboratory results of blood (hemogramme, biochemistry, coagulation) and urine. The results observed in 500 patients, (250 of each heparin) statistically treated, show that no difference was found between the two groups of patients, which lead us to conclude that both heparins have the same effect. Low molecular weight has the advantage of being administrated only once a day. |
id |
RCAP_785850ba25049ffd6c5dea7f75d27794 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/2556 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Prophylaxis of postoperative thromboembolism. Randomized prospective study.Profilaxia da tromboembolia pós-operatória. Estudo prospectivo randomizado.The difference between a non fractioned heparin (Liquemine) and another of low molecular weight (Fraxiparine) was compared through: hemostasis difficulties, during and after surgery; the use of transfusions; clinical signs of inferior limb vein thrombosis or pulmonary emboli; laboratory results of blood (hemogramme, biochemistry, coagulation) and urine. The results observed in 500 patients, (250 of each heparin) statistically treated, show that no difference was found between the two groups of patients, which lead us to conclude that both heparins have the same effect. Low molecular weight has the advantage of being administrated only once a day.The difference between a non fractioned heparin (Liquemine) and another of low molecular weight (Fraxiparine) was compared through: hemostasis difficulties, during and after surgery; the use of transfusions; clinical signs of inferior limb vein thrombosis or pulmonary emboli; laboratory results of blood (hemogramme, biochemistry, coagulation) and urine. The results observed in 500 patients, (250 of each heparin) statistically treated, show that no difference was found between the two groups of patients, which lead us to conclude that both heparins have the same effect. Low molecular weight has the advantage of being administrated only once a day.Ordem dos Médicos1996-03-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556oai:ojs.www.actamedicaportuguesa.com:article/2556Acta Médica Portuguesa; Vol. 9 No. 2-3 (1996): Fevereiro-Março; 87-90Acta Médica Portuguesa; Vol. 9 N.º 2-3 (1996): Fevereiro-Março; 87-901646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556/1969Manso, L CMilheiro, ACastro e Sousa, Finfo:eu-repo/semantics/openAccess2022-12-20T11:00:45Zoai:ojs.www.actamedicaportuguesa.com:article/2556Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:17:49.735821Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. Profilaxia da tromboembolia pós-operatória. Estudo prospectivo randomizado. |
title |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. |
spellingShingle |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. Manso, L C |
title_short |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. |
title_full |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. |
title_fullStr |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. |
title_full_unstemmed |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. |
title_sort |
Prophylaxis of postoperative thromboembolism. Randomized prospective study. |
author |
Manso, L C |
author_facet |
Manso, L C Milheiro, A Castro e Sousa, F |
author_role |
author |
author2 |
Milheiro, A Castro e Sousa, F |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Manso, L C Milheiro, A Castro e Sousa, F |
description |
The difference between a non fractioned heparin (Liquemine) and another of low molecular weight (Fraxiparine) was compared through: hemostasis difficulties, during and after surgery; the use of transfusions; clinical signs of inferior limb vein thrombosis or pulmonary emboli; laboratory results of blood (hemogramme, biochemistry, coagulation) and urine. The results observed in 500 patients, (250 of each heparin) statistically treated, show that no difference was found between the two groups of patients, which lead us to conclude that both heparins have the same effect. Low molecular weight has the advantage of being administrated only once a day. |
publishDate |
1996 |
dc.date.none.fl_str_mv |
1996-03-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556 oai:ojs.www.actamedicaportuguesa.com:article/2556 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/2556 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2556/1969 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 9 No. 2-3 (1996): Fevereiro-Março; 87-90 Acta Médica Portuguesa; Vol. 9 N.º 2-3 (1996): Fevereiro-Março; 87-90 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130631385382912 |